Khan et al., 2018 - Google Patents
FMSP-nanoparticles induced cell death on human breast adenocarcinoma cell line (MCF-7 cells): morphometric analysisKhan et al., 2018
View HTML- Document ID
- 1361238210105577957
- Author
- Khan F
- Akhtar S
- Almofty S
- Almohazey D
- Alomari M
- Publication year
- Publication venue
- Biomolecules
External Links
Snippet
Currently, breast cancer treatment mostly revolves around radiation therapy and surgical interventions, but often these treatments do not provide satisfactory relief to the patients and cause unmanageable side-effects. Nanomaterials show promising results in treating cancer …
- 239000002105 nanoparticle 0 title abstract description 140
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Khan et al. | FMSP-nanoparticles induced cell death on human breast adenocarcinoma cell line (MCF-7 cells): morphometric analysis | |
Wang et al. | Anticancer effects of resveratrol-loaded solid lipid nanoparticles on human breast cancer cells | |
Wang et al. | Curcumin-loaded solid lipid nanoparticles enhanced anticancer efficiency in breast cancer | |
Al-Musawi et al. | Design and synthesis of multi-functional superparamagnetic core-gold shell nanoparticles coated with chitosan and folate for targeted antitumor therapy | |
Lomis et al. | Human serum albumin nanoparticles for use in cancer drug delivery: process optimization and in vitro characterization | |
Albuquerque et al. | Solid lipid nanoparticles: a potential multifunctional approach towards rheumatoid arthritis theranostics | |
Liszbinski et al. | Anti-EGFR-coated gold nanoparticles in vitro carry 5-fluorouracil to colorectal cancer cells | |
Aldawsari et al. | Rapid microwave-assisted cisplatin-loaded solid lipid nanoparticles: synthesis, characterization and anticancer study | |
Go et al. | Prpc aptamer conjugated–gold nanoparticles for targeted delivery of doxorubicin to colorectal cancer cells | |
Alsaab et al. | Folate decorated nanomicelles loaded with a potent curcumin analogue for targeting retinoblastoma | |
Hanafy et al. | Inihibition of glycolysis by using a micro/nano-lipid bromopyruvic chitosan carrier as a promising tool to improve treatment of hepatocellular carcinoma | |
Kim et al. | Glycol chitosan-docosahexaenoic acid liposomes for drug delivery: synergistic effect of doxorubicin-rapamycin in drug-resistant breast cancer | |
Sharma et al. | Poly-(lactic-co-glycolic) acid nanoparticles for synergistic delivery of epirubicin and paclitaxel to human lung cancer cells | |
Aldawsari et al. | Gum acacia functionalized colloidal gold nanoparticles of letrozole as biocompatible drug delivery carrier for treatment of breast cancer | |
Nasr et al. | Bioavailability and antidiabetic activity of gliclazide-loaded cubosomal nanoparticles | |
Massadeh et al. | Optimized polyethylene glycolylated polymer–lipid hybrid nanoparticles as a potential breast cancer treatment | |
Suresh et al. | Development of a novel methotrexate-loaded nanoemulsion for rheumatoid arthritis treatment with site-specific targeting subcutaneous delivery | |
Pilch et al. | Quantum dots as a good carriers of unsymmetrical bisacridines for modulating cellular uptake and the biological response in lung and colon cancer cells | |
Sharma et al. | Diosgenin loaded polymeric nanoparticles with potential anticancer efficacy | |
Abou-ElNaga et al. | Novel nano-therapeutic approach actively targets human ovarian cancer stem cells after xenograft into nude mice | |
Streets et al. | Sunitinib-loaded MPEG-PCL micelles for the treatment of age-related macular degeneration | |
Salama et al. | The effects of TiO2 nanoparticles on cisplatin cytotoxicity in cancer cell lines | |
Liu et al. | Targeted co-delivery of gefitinib and rapamycin by aptamer-modified nanoparticles overcomes EGFR-TKI resistance in NSCLC via promoting autophagy | |
Fatemian et al. | Cytotoxicity enhancement in breast cancer cells with carbonate apatite-facilitated intracellular delivery of anti-cancer drugs | |
Kovalenko et al. | Lectin-modified magnetic nano-PLGA for photodynamic therapy in vivo |